We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$84.7B
AUM Growth
+$3.15B
Cap. Flow
-$3.2B
Cap. Flow %
-3.77%
Top 10 Hldgs %
10.93%
Holding
2,264
New
35
Increased
617
Reduced
853
Closed
525

Top Buys

Rank Stock Value
1
LHX icon
L3Harris
LHX
+$128M
2
DHR icon
Danaher
DHR
+$114M
3
ZBRA icon
Zebra Technologies
ZBRA
+$112M
4
AIZ icon
Assurant
AIZ
+$92.7M
5
EXC icon
Exelon
EXC
+$92.2M

Sector Composition

Rank Sector Weight
1 Technology 21.36%
2 Healthcare 15.17%
3 Financials 13.51%
4 Industrials 10.72%
5 Consumer Discretionary 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXPE icon
1376
Expedia Group
EXPE
$31.2B
$944K ﹤0.01%
10,771
+1,099
+11% +$104K
TDG icon
1377
TransDigm Group
TDG
$69.2B
$943K ﹤0.01%
1,498
+301
+25% +$177K
PUBM icon
1378
PubMatic
PUBM
$581M
$938K ﹤0.01%
73,192
-95,042
-56% -$1.49M
OGN icon
1379
Organon & Co
OGN
$3.55B
$930K ﹤0.01%
33,300
-2,251
-6% -$57.6K
LVS icon
1380
Las Vegas Sands
LVS
$30.5B
$925K ﹤0.01%
19,255
+4,514
+31% +$192K
GEN icon
1381
Gen Digital
GEN
$15.6B
$924K ﹤0.01%
43,129
-269
-0.6% -$5.94K
ALLO icon
1382
Allogene Therapeutics
ALLO
$601M
$923K ﹤0.01%
146,779
-593
-0.4% -$5.49K
WMG icon
1383
Warner Music
WMG
$13.8B
$922K ﹤0.01%
26,325
-9,470
-26% -$276K
MC icon
1384
Moelis & Co
MC
$4.98B
$921K ﹤0.01%
23,992
-5,822
-20% -$236K
GLIN icon
1385
VanEck India Growth Leaders ETF
GLIN
$93.7M
$912K ﹤0.01%
27,909
WCN
1386
Waste Connections
WCN
$42.8B
$904K ﹤0.01%
6,816
-38
-0.6% -$5.17K
XRX icon
1387
Xerox
XRX
$337M
$895K ﹤0.01%
61,300
-3,145
-5% -$47.4K
DCH
1388
Dauch Corp
DCH
$1.3B
$893K ﹤0.01%
114,200
-1,446
-1% -$13K
FORM icon
1389
FormFactor
FORM
$8.11B
$883K ﹤0.01%
39,727
-14,076
-26% -$328K
MRSN
1390
DELISTED
Mersana Therapeutics
MRSN
$879K ﹤0.01%
6,000
-152
-2% -$25.7K
JHG
1391
DELISTED
Janus Henderson
JHG
$867K ﹤0.01%
36,855
-35,262
-49% -$827K
WMK icon
1392
Weis Markets
WMK
$1.82B
$862K ﹤0.01%
10,470
-8,030
-43% -$678K
TX icon
1393
Ternium
TX
$9.29B
$860K ﹤0.01%
28,157
-12,087
-30% -$361K
HGAS
1394
DELISTED
Global Gas Corporation Class A Common Stock
HGAS
$859K ﹤0.01%
90,000
SWTX
1395
DELISTED
SpringWorks Therapeutics
SWTX
$856K ﹤0.01%
32,928
+32,792
+24,112% +$808K
ZUO
1396
DELISTED
Zuora, Inc.
ZUO
$854K ﹤0.01%
134,200
-41,729
-24% -$295K
BEKE icon
1397
KE Holdings
BEKE
$16.8B
$850K ﹤0.01%
60,905
+12,321
+25% +$171K
CTO
1398
CTO Realty Growth
CTO
$743M
$850K ﹤0.01%
46,500
HRL icon
1399
Hormel Foods
HRL
$13.9B
$849K ﹤0.01%
18,624
+7,768
+72% +$362K
ZM icon
1400
Zoom
ZM
$25.8B
$843K ﹤0.01%
12,439
+20
+0.2% +$1.52K

Similar funds

Macquarie Group's Q4 2022 Portfolio in Review

As of Q4 2022, Macquarie Group held 2,264 positions worth $84.7B, up 3.9% from $81.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Macquarie Group withdrew a net $3.2B in Q4 2022, closing 525 positions and reducing 853 holdings. Its most notable exit was Abiomed Inc, an estimated $124M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Macquarie Group opened a new position in iShares 0-5 Year Investment Grade Corporate Bond ETF worth $58.3M.

  • Macquarie Group's largest Q4 2022 buy was iShares 0-5 Year Investment Grade Corporate Bond ETF: 1,218,670 shares worth $58.3M.
  • Macquarie Group added most to L3Harris in Q4 2022, an estimated $128M increase.
  • Macquarie Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $189M.
  • Macquarie Group fully exited Abiomed Inc in Q4 2022, selling an estimated $124M.
  • Macquarie Group's ten largest holdings make up 11% of its $84.7B portfolio in Q4 2022.
  • Macquarie Group opened 35 new positions and closed 525 in Q4 2022.
  • Macquarie Group's portfolio value rose 3.9% quarter-over-quarter to $84.7B.

Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.